Literature DB >> 6105456

Anti-mitochondrial antibodies associated with labetalol.

J D Wilson, R J Booth, J Y Bullock, D G Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6105456     DOI： 10.1016/s0140-6736(80)90255-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.

Authors:  W H Frishman
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

2.  Review of long-term treatment with labetalol.

Authors:  H J Waal-Manning; F O Simpson
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 3.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.